Active Ingredient
Lidocaine Hydrochloride 2%
Lidocaine Hydrochloride 2% Gel
FDA Label NDC 87236-015
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Aldermed Inc. for the product Lidocaine Hydrochloride 2% (NDC 87236-015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use(s), warnings, do not use, when using this product, stop use and ask a doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
External Analgesic
Use(S)
■ For the temporary relief of pain associated with ■ Minor burns ■ Sunburn
Warnings
For External Use Only
Do Not Use
■ On wounds or damaged skin
■ In large quantities, particularly over raw surfaces or blistered areas
When Using This Product
■ Avoid contact with the eyes
■ Do not bandage tightly
Stop Use And Ask A Doctor If
■ Condition worsens
■ Symptoms persist for more than 7 days
■ Symptoms clear up and occur again within a few days
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center right away.(1-800-222-1222)
Directions
■ Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily
■ Children under 2 years of age: Consult a doctor
Other Information
• Store at room temperature
• Tamper Evident. Do not use if seal is torn, cut, or opened.
- See sachet or cartonfor lot number and expiry date
Inactive Ingredients
Acrylates/C10-30 Alkyl Acrylate Crosscopolymer, Carbomer, Glycerin, Imidurea, Methylparaben, Propylene Glycol, Propylparaben, Purified Water, Tea Tree Leaf Oil, Trolamine
Questions?
1-888-396-2739 Monday - Friday, 9AM - 5PM EST
* Please review the disclaimer below.
